The lncRNA XIST serves as a miR-34a ceRNA via competing with MET for miR-34a binding and thus promoting cancer cell proliferation and tumor growth through upregulated MET–PI3K–AKT signaling (Liu et al., 2018). The gene discussed is MET; the disease is cancer.